Zocor vs. Livalo

See how Zocor and Livalo compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Both are once-daily statins that lower LDL cholesterol, but Zocor is available as a low-cost generic while Livalo remains brand-only.

  • Zocor carries added FDA-approved indications for reducing heart attack, stroke, and death risk in high-risk patients, while Livalo's approved uses focus on cholesterol reduction itself.

  • Livalo has fewer CYP3A4 drug interactions than Zocor, which is contraindicated with strong CYP3A4 inhibitors.

Zocor vs. Livalo Drug Summary

Zocor

Zocor (simvastatin) is a statin that lowers LDL cholesterol and is also approved to reduce the risk of heart attack, stroke, and death in people at high cardiovascular risk. It is taken as a once-daily oral tablet and has been available as a low-cost generic for years.

Livalo

Livalo (pitavastatin) is a statin that lowers LDL cholesterol, total cholesterol, and triglycerides in adults with high cholesterol or mixed dyslipidemia, and in people with familial hypercholesterolemia. It is taken as a once-daily oral tablet and is only available as a brand-name drug.

Zocor vs. Livalo Side Effects

Zocor

Most common
upper respiratory infection (up to 9%)
constipation (up to 7%)
headache (up to 7%)
abdominal pain (up to 7%)

Livalo

Most common
myalgia (1.9% to 3.1%)
constipation (1.5% to 3.6%)
diarrhea (1.5% to 2.6%)
back pain (1.4% to 3.9%)

Zocor vs. Livalo Dosage

Zocor

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 80 mg once daily If needed
Dose changes 3 increases As tolerated

Livalo

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily At the start
Maximum dose 4 mg once daily If needed
Dose changes 2 increases As tolerated

Zocor vs. Livalo Indications

Zocor

Zocor is FDA-approved to lower LDL cholesterol in adults with high cholesterol and to treat both heterozygous and homozygous familial hypercholesterolemia. It also carries an approved indication for reducing the risk of heart attack, stroke, and death in people with heart disease or diabetes at high cardiovascular risk.

  • Lower LDL cholesterol in adults with primary hyperlipidemia

  • Treat heterozygous familial hypercholesterolemia (ages 10+)

  • Adjunct therapy for homozygous familial hypercholesterolemia

  • Reduce risk of heart attack, stroke, and death in high-risk adults

Livalo

Livalo is FDA-approved to lower LDL cholesterol, total cholesterol, and triglycerides in adults with high cholesterol or mixed dyslipidemia, and to lower LDL cholesterol in people with heterozygous familial hypercholesterolemia, including children as young as 8. Unlike Zocor, it does not carry an FDA-approved indication for reducing cardiovascular events.

  • Lower LDL-C, cholesterol, and triglycerides in hyperlipidemia or mixed dyslipidemia

  • Reduce LDL-C in adults with heterozygous familial hypercholesterolemia

  • Reduce LDL-C in children 8+ with heterozygous familial hypercholesterolemia

  • Off-label: primary prevention of cardiovascular disease

Zocor vs. Livalo Pros and Cons

Zocor

Zocor has the longest track record of any statin on this list, backed by decades of outcomes data and a widely available low-cost generic. Its main tradeoffs are a stricter drug interaction profile and dose-dependent muscle risk at the 80 mg ceiling.

Pros

  • Available as low-cost generic, typically $75 to $100 per month without insurance

  • FDA-approved to reduce risk of heart attack, stroke, and death in high-risk patients

  • Decades of long-term safety data since its 1991 approval

  • Multiple dose strengths (10-80 mg) allow flexible titration

Cons

  • Contraindicated with strong CYP3A4 inhibitors, limiting use with certain common drugs

  • Higher risk of myopathy and rhabdomyolysis at the 80 mg dose

  • 80 mg dose restricted to patients already tolerating it for 12+ months

  • Not approved for children under 10

Livalo

Livalo offers a cleaner drug interaction profile than many statins because it is minimally metabolized through CYP3A4, and it is approved for children as young as 8. As a brand-only medication, it costs substantially more each month than generic Zocor.

Pros

  • Minimal CYP3A4 metabolism means fewer drug-drug interactions

  • No history of an FDA boxed warning for high-dose muscle risk

  • Approved down to age 8 for heterozygous familial hypercholesterolemia

  • Bioequivalent alternative (Zypitamag) available if needed

Cons

  • No generic for brand Livalo; roughly $315 to $410 per month without insurance

  • Contraindicated with cyclosporine due to sharply increased drug exposure

  • Not approved for reducing cardiovascular events, only cholesterol reduction

  • Fewer dose strength options (1-4 mg) than Zocor

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.